目的测定注射用头孢曲松钠的含量。
OBJECTIVE To determine the content of Ceftriaxone sodium for injection.
临床上头孢曲松钠与复方氯化钠不能配伍使用。
The compatibility of ceftriaxone sodium with composite sodium chloride injection should be avoided in clinic.
目的观察头孢曲松钠治疗小儿细菌性腹泻病疗效。
Objective To observe the curative effect of children bacterial diarrhea treated with ceftriaxone sodium.
头孢曲松钠、米诺环素、多西环素则是有效的驱梅替代药物。
Ceftriaxone sodium, minocycline, doxycycline are valid alternative medicines for syphilis.
一种叫左氧氟沙星，一种叫头孢曲松钠，最后一种叫替硝唑。
One is Levofloxacin, one is Ceftriaxone Sodium, the last one is tindazole.
结论：临床医生应重视头孢曲松钠的不良反应监测，合理用药。
Conclusion: Clinical physicians and pharmaceutists should pay attention to ADRs of ceftriaxone sodium and rational drug use.
目的：探讨头孢曲松钠对急性非复杂性泌尿系感染的临床疗效。
Objective: To study the efficacy of ceftriaxone in treatment of acute non complicated urinary tract infections.
方法42例早期梅毒患者分两组行不同剂量的头孢曲松钠肌注10天。
Methods 42 syphilitics were put into two groups and treated with different doses for 10 days of muscular injection.
结论阿奇霉素联合头孢曲松钠治疗重症社区获得性肺炎优于上述单种抗生素。
Conclusion There is a better efficacy of combining azithromycin with ceftriaxone sodium for treating severity community acquired pneumonia than azithromycin or ceftriaxone sodium used individually.
结论应重视头孢曲松钠引起adr的各种因素，采取有效措施预防或治疗adr。
Conclusion Attention should be paid to the multiple factors causing ADRs of ceftriaxone sodium, and measures should be taken to prevent and control the ADRs.
前言：目的：探讨头孢曲松钠所致不良反应的一般规律和特点，以指导临床合理用药。
Objective: to research the regularity and features of adverse drug reactions (ADRs) associated with ceftriaxone sodium and to guide rational drug use.
结果：抗菌药物的使用率为64．58％，其中头孢曲松钠针、利巴韦林针用药频率较高；
Results:Antibiotics's utilization ratio is 64.58 ~, the spore Qusum sodium needle, Layman the Welling needle medication frequency is high;
分离菌株对青霉素、磺胺甲基异恶唑具抗药性，对氨苄青霉素、环丙沙星、头孢曲松钠高敏。
The isolates were resistant to penicillin G and sulfamethoxazole, and highly sensitive to ampicillin, ciprofloxacin and ceftriazone.
标题：罗氏芬（头孢曲松钠）标签中禁忌症，注意事项，警告，不良反应，剂量和用法的修订。
Title: Rocephin (Ceftriaxone Sodium) - Contraindications, Warnings, Precautions, Adverse Reactions, Dosage and Administration Sections of Labeling Revised.
兹证明我司09年1月13日发的信用证（证号：20309IM00005）项下的货物：头孢曲松钠符合企业标准。
We are certifying that the goods:ceftriaxone sodium(non sterile)shipped on Jan. 13,2009 under LC 20309IM00005 conform to the in-house specification.
方法：利用HPLC，分离了头孢曲松钠及其在输液中的分解产物，采用归一法的定量方法，进行头孢曲松钠的含量分析。
Method: a HPLC method was used to separate ceftriaxone and its decomposition products. Return-to-one method was used as quantitative analysis method.
方法：利用HPLC，分离了头孢曲松钠及其在输液中的分解产物，采用归一法的定量方法，进行头孢曲松钠的含量分析。
Method: a HPLC method was used to separate ceftriaxone and its decomposition products. Return-to-one method was used as quantitative analysis method.
应用推荐